$CPSH
CPS TECHNOLOGIES CORP/DE/

2024 Q4 Form 10-Q Financial Statement

#000143774924032936 Filed on November 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $4.247M
YoY Change -42.75%
Cost Of Revenue $4.771M
YoY Change -8.64%
Gross Profit -$523.4K
YoY Change -123.83%
Gross Profit Margin -12.32%
Selling, General & Admin $963.1K
YoY Change -34.28%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $131.7K
YoY Change 2.64%
% of Gross Profit
Operating Expenses $963.1K
YoY Change -34.28%
Operating Profit -$1.486M
YoY Change -303.38%
Interest Expense $71.65K
YoY Change -5368.38%
% of Operating Profit
Other Income/Expense, Net -$676.00
YoY Change -100.83%
Pretax Income -$1.416M
YoY Change -274.63%
Income Tax -$372.7K
% Of Pretax Income
Net Earnings -$1.043M
YoY Change -273.66%
Net Earnings / Revenue -24.55%
Basic Earnings Per Share -$0.07
Diluted Earnings Per Share -$0.07
COMMON SHARES
Basic Shares Outstanding 14.53M 14.53M
Diluted Shares Outstanding 14.53M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.693M
YoY Change -34.43%
Cash & Equivalents $4.689M
Short-Term Investments $1.004M
Other Short-Term Assets $506.1K
YoY Change 75.54%
Inventory $4.433M
Prepaid Expenses
Receivables $3.655M
Other Receivables $0.00
Total Short-Term Assets $14.67M
YoY Change -22.53%
LONG-TERM ASSETS
Property, Plant & Equipment $2.082M
YoY Change 38.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.250M
YoY Change 35.21%
Total Long-Term Assets $4.556M
YoY Change 27.57%
TOTAL ASSETS
Total Short-Term Assets $14.67M
Total Long-Term Assets $4.556M
Total Assets $19.22M
YoY Change -14.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.497M
YoY Change 5.83%
Accrued Expenses $840.8K
YoY Change -2.41%
Deferred Revenue $160.4K
YoY Change -91.23%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $20.10K
YoY Change -64.54%
Total Short-Term Liabilities $3.678M
YoY Change -30.12%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change -100.0%
Other Long-Term Liabilities $95.28K
YoY Change -65.13%
Total Long-Term Liabilities $95.28K
YoY Change -67.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.678M
Total Long-Term Liabilities $95.28K
Total Liabilities $3.774M
YoY Change -32.1%
SHAREHOLDERS EQUITY
Retained Earnings -$24.90M
YoY Change 7.93%
Common Stock $146.6K
YoY Change 0.79%
Preferred Stock
YoY Change
Treasury Stock (at cost) $340.1K
YoY Change
Treasury Stock Shares
Shareholders Equity $15.45M
YoY Change
Total Liabilities & Shareholders Equity $19.22M
YoY Change -14.58%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$1.043M
YoY Change -273.66%
Depreciation, Depletion And Amortization $131.7K
YoY Change 2.64%
Cash From Operating Activities -$1.187M
YoY Change -176.34%
INVESTING ACTIVITIES
Capital Expenditures $80.15K
YoY Change -68.81%
Acquisitions
YoY Change
Other Investing Activities -$253.5K
YoY Change
Cash From Investing Activities -$333.7K
YoY Change 29.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -11.78K
YoY Change -188.04%
NET CHANGE
Cash From Operating Activities -1.187M
Cash From Investing Activities -333.7K
Cash From Financing Activities -11.78K
Net Change In Cash -1.533M
YoY Change -216.86%
FREE CASH FLOW
Cash From Operating Activities -$1.187M
Capital Expenditures $80.15K
Free Cash Flow -$1.267M
YoY Change -197.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-28
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0000814676
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0
CY2023Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
0 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
0 usd
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-28
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-16088
dei Entity Registrant Name
EntityRegistrantName
CPS TECHNOLOGIES CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-2832509
dei Entity Address Address Line1
EntityAddressAddressLine1
111 South Worcester Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Norton
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02766-2102
dei City Area Code
CityAreaCode
508
dei Local Phone Number
LocalPhoneNumber
222-0614
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
dei Trading Symbol
TradingSymbol
CPSH
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14525960
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4689004 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8813626 usd
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1020952 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3654549 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4389155 usd
CY2024Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
362312 usd
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
83191 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
4433412 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
4581930 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
506126 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
276349 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
14666355 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
18144251 usd
CY2024Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
9953702 usd
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
11271982 usd
CY2024Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
891921 usd
CY2023Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
952883 usd
CY2024Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
988804 usd
CY2023Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
985649 usd
CY2024Q3 cpsh Property Plant And Equipment Gross Excluding Construction In Progress
PropertyPlantAndEquipmentGrossExcludingConstructionInProgress
11834427 usd
CY2023Q4 cpsh Property Plant And Equipment Gross Excluding Construction In Progress
PropertyPlantAndEquipmentGrossExcludingConstructionInProgress
13210514 usd
CY2024Q3 cpsh Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Excluding Construction In Progress
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingConstructionInProgress
10200302 usd
CY2023Q4 cpsh Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Excluding Construction In Progress
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingConstructionInProgress
11936004 usd
CY2024Q3 cpsh Construction In Progress Net
ConstructionInProgressNet
448184 usd
CY2023Q4 cpsh Construction In Progress Net
ConstructionInProgressNet
281629 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2082309 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1556139 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
224000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
332000 usd
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2249985 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1569726 usd
CY2024Q3 us-gaap Assets
Assets
19222649 usd
CY2023Q4 us-gaap Assets
Assets
21602116 usd
CY2024Q3 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
20103 usd
CY2023Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
46797 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2497055 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2535086 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
840757 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1075137 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
160412 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
251755 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
160000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
160000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3678327 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4068775 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
8090 usd
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
31277 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
31277 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
64000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
172000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
3773604 usd
CY2023Q4 us-gaap Liabilities
Liabilities
4280142 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14661487
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14525960
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14601487
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14519215
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
146615 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
146015 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
40520215 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
40180893 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
17446 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24895093 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22754796 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
135527
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
82272
CY2024Q3 us-gaap Treasury Stock Value
TreasuryStockValue
340138 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
250138 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
15449045 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
17321974 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19222649 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21602116 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4247116 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6285041 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15190063 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20803447 usd
CY2024Q3 us-gaap Revenues
Revenues
4247116 usd
CY2023Q3 us-gaap Revenues
Revenues
6285041 usd
us-gaap Revenues
Revenues
15190063 usd
us-gaap Revenues
Revenues
20803447 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4770548 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5049177 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15037177 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15126621 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
-523432 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
1235864 usd
us-gaap Gross Profit
GrossProfit
152886 usd
us-gaap Gross Profit
GrossProfit
5676826 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
963064 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1105227 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3214831 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4121099 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1486496 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
130637 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3061945 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1555727 usd
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
71650 usd
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
78181 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
241686 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
176325 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-676 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1228 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
159 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4130 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1415522 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
207590 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2820100 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1727922 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-372683 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
36509 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-679803 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
497137 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1042839 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
171081 usd
us-gaap Net Income Loss
NetIncomeLoss
-2140297 usd
us-gaap Net Income Loss
NetIncomeLoss
1230785 usd
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
8745 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
17446 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
8745 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
17446 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1034094 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
171081 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2122851 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1230785 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14525664
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14517364
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14521365
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14487873
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14525664
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14636241
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14521365
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14632591
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
16438659 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
44480 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
8745 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1042839 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
15449045 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
17321974 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
249922 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
17446 usd
us-gaap Net Income Loss
NetIncomeLoss
-2140297 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
15449045 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16946592 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
27941 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7750 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
171081 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
17153364 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
15705516 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
175698 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
41365 usd
us-gaap Net Income Loss
NetIncomeLoss
1230785 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
17153364 usd
us-gaap Net Income Loss
NetIncomeLoss
-2140297 usd
us-gaap Net Income Loss
NetIncomeLoss
1230785 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
369698 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
363308 usd
us-gaap Share Based Compensation
ShareBasedCompensation
249922 usd
us-gaap Share Based Compensation
ShareBasedCompensation
175698 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
680259 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-423969 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-734606 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1228476 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
279122 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-668625 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-148518 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-47944 usd
cpsh Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
145063 usd
cpsh Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
126234 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-38030 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
314262 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-234379 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
246437 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-91343 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1045785 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2105749 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1070533 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
895868 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
567349 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1003506 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1899374 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-567349 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
41365 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
34784 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
32446 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-34784 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8919 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4039907 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
512103 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8813626 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8266753 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4773719 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8778856 usd
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
84715 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4689004 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8778856 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
432 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
109456 usd
us-gaap Interest Paid Net
InterestPaidNet
1917 usd
us-gaap Interest Paid Net
InterestPaidNet
4130 usd
us-gaap Stock Issued1
StockIssued1
90000 usd
us-gaap Stock Issued1
StockIssued1
209290 usd
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
84715 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4689004 usd
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
84715 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4773719 usd
CY2024Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
1020952 usd
CY2024Q3 us-gaap Marketable Securities
MarketableSecurities
1003506 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
17446 usd
CY2024Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
1020952 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1042839 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
171081 usd
us-gaap Net Income Loss
NetIncomeLoss
-2140297 usd
us-gaap Net Income Loss
NetIncomeLoss
1230785 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14525664
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14517364
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14521365
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14487873
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1042839 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
171081 usd
us-gaap Net Income Loss
NetIncomeLoss
-2140297 usd
us-gaap Net Income Loss
NetIncomeLoss
1230785 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14525664
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14517364
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14521365
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14487873
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
118877
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
144718
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14525664
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14636241
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14521365
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14632591
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2024Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
38000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
41000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
165000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
28000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
234000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
10000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
224000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
160000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
64000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
224000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P17M
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.066 pure
CY2024Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
60000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
60000
CY2024Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.5
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.5
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
53100
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
69200
CY2023Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
55000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
141001
CY2023Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.65
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.78
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
27400
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
233000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
25000
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
53255
CY2024Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
53255
CY2023Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
47329
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
72256
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
984800
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.68
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M23D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
543800
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.58
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y1M17D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
1500000
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
604000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y1M24D
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
44480 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
249922 usd
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
27941 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
175698 usd
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
2660125 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2861333 usd
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1861794 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1493582 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
423453 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
537975 usd
CY2024Q3 us-gaap Inventory Gross
InventoryGross
4945372 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
4892890 usd
CY2024Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
511960 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
310960 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
4433412 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
4581930 usd
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
80796 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
86000 usd
CY2024Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
402118 usd
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
649201 usd
CY2024Q3 cpsh Accrued Product Returns
AccruedProductReturns
288000 usd
CY2023Q4 cpsh Accrued Product Returns
AccruedProductReturns
288000 usd
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
69843 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
51936 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
840757 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1075137 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
12013 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
8090 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
20103 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
1917 usd
CY2024Q3 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
372683 usd
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
680259 usd

Files In Submission

Name View Source Status
0001437749-24-032936-index-headers.html Edgar Link pending
0001437749-24-032936-index.html Edgar Link pending
0001437749-24-032936.txt Edgar Link pending
0001437749-24-032936-xbrl.zip Edgar Link pending
cpsh-20240928.xsd Edgar Link pending
cpsh20240928_10q.htm Edgar Link pending
ex_737387.htm Edgar Link pending
ex_737388.htm Edgar Link pending
ex_737389.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
cpsh20240928_10q_htm.xml Edgar Link completed
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cpsh-20240928_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cpsh-20240928_def.xml Edgar Link unprocessable
cpsh-20240928_lab.xml Edgar Link unprocessable
cpsh-20240928_pre.xml Edgar Link unprocessable